Skip to content

Insider · CIK 0002020521

Kneafsey Brian

officer

Files at BLND (Blend Labs, Inc.). First filing Dec 12, 2024, latest Dec 27, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $437k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
21Weaksell 310b5-1BLND
Blend Labs, Inc.
$132k30,000-3%-
21Weaksell 410b5-1BLND
Blend Labs, Inc.
$151k30,000-3%-
21Weaksell 410b5-1BLND
Blend Labs, Inc.
$154k30,000-3%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 24, 2024BLND
Blend Labs, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-30,000$4.40$132k926,759Dec 27, 2024
Dec 20, 2024BLND
Blend Labs, Inc.
MOption exercise
Class A Common Stock
+100,000$0.00$01,007,439Dec 23, 2024
Dec 20, 2024BLND
Blend Labs, Inc.
FTax withholding
Class A Common Stock
-50,680$4.70$238k956,759Dec 23, 2024
Dec 20, 2024BLND
Blend Labs, Inc.
MOption exercise
Performance-based Restricted Stock Unitsderivative
-100,000$0.00$0300,000Dec 23, 2024
Dec 17, 2024BLND
Blend Labs, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-30,000$5.05$151k907,439Dec 18, 2024
Dec 10, 2024BLND
Blend Labs, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-30,000$5.12$154k937,439Dec 12, 2024
Nov 20, 2024BLND
Blend Labs, Inc.
MOption exercise
Class A Common Stock
+75,000--1,005,450Nov 22, 2024
Nov 20, 2024BLND
Blend Labs, Inc.
FTax withholding
Class A Common Stock
-38,011$4.97$189k967,439Nov 22, 2024
Nov 20, 2024BLND
Blend Labs, Inc.
MOption exercise
Restricted Stock Unitsderivative
-75,000$0.00$0375,000Nov 22, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.